Jacobs Levy Equity Management’s Omnicell OMCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16.8M Buy
502,700
+427,507
+569% +$17.9M 0.07% 231
2025
Q4
$3.41M Buy
75,193
+12,018
+19% +$440K 0.01% 489
2025
Q3
$1.92M Buy
+63,175
New +$1.94M 0.01% 600
2025
Q2
Sell
-24,884
Closed -$870K 1128
2025
Q1
$870K Buy
+24,884
New +$987K ﹤0.01% 832
2024
Q2
Sell
-73,506
Closed -$2.15M 1021
2024
Q1
$2.15M Sell
73,506
-391,313
-84% -$11.9M 0.01% 586
2023
Q4
$17.5M Sell
464,819
-17,669
-4% -$650K 0.09% 226
2023
Q3
$21.7M Buy
482,488
+478,636
+12,426% +$29M 0.13% 171
2023
Q2
$284K Buy
+3,852
New +$260K ﹤0.01% 885
2014
Q1
Sell
-9,938
Closed -$254K 978
2013
Q4
$254K Sell
9,938
-18,962
-66% -$453K ﹤0.01% 836
2013
Q3
$684K Sell
28,900
-67,907
-70% -$1.51M 0.01% 608
2013
Q2
$1.99M Buy
+96,807
New +$1.79M 0.04% 418

Other funds holding OMCL

Jacobs Levy Equity Management's OMCL Position: Q1 2026 in Review

Jacobs Levy Equity Management increased its Omnicell (OMCL) stake by 569% in Q1 2026, buying an estimated $17.9M and bringing the position to 502,700 shares worth $16.8M. The position accounts for 0.07% of the portfolio, ranked #231.

Jacobs Levy Equity Management first reported a position in OMCL in Q2 2013 and has held it in 11 quarters since. The position peaked at $21.7M in Q3 2023. 272 funds tracked by Wall St. Rank hold OMCL as of Q1 2026.

  • Jacobs Levy Equity Management held 502,700 shares of Omnicell worth $16.8M as of Q1 2026.
  • Jacobs Levy Equity Management bought 427,507 Omnicell shares in Q1 2026, an estimated $17.9M.
  • Omnicell made up 0.07% of Jacobs Levy Equity Management's portfolio in Q1 2026, its #231 holding.
  • Jacobs Levy Equity Management first reported a position in Omnicell in Q2 2013 and has held it in 11 quarters since.
  • Jacobs Levy Equity Management's Omnicell position peaked at $21.7M in Q3 2023.
  • 272 funds tracked by Wall St. Rank held Omnicell as of Q1 2026.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2026, filed 15 May 2026.